Skip to content
Saturday 18 July 2026EN · DE
City PM

European business, markets and politics

  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Tuesday 14 December 2021 4:18 pm

Derwent London to buy the Moorfields Eye Hospital 

By: Emily Hawkins

Add as a preferred source on Google

Derwent London has been selected as the preferred bidder to buy the freehold of the Moorfields Eye Hospital. 

The Moorfields Eye Hospital NHS Foundation Trust and UCL selected the property investment firm for the acquisition of the freehold of City Road Island and 11-43 Bath Street.

Derwent will purchase 2.5 acres and 400,000 sq ft, in a deal that will see it submit a planning application next year for the site’s redevelopment. 

The acquisition is expected to complete in the second half of 2026 following the completion of a new eye care, research and education centre in Camden.

Paul Williams, chief executive of Derwent London, said: “We are delighted to be acquiring this well located major regeneration opportunity close to our existing holdings in Islington.”

Martin Kuper, chief executive of Moorfields Eye Hospital NHS Foundation Trust said all proceeds of the sale would be reinvested in the new centre “to secure the long-term future of world-leading eye care, research and education in a way that represents value for money.”

He added: “Arrangements will be put in place for a smooth transition from the existing sites to the new one, with minimal disruption to the delivery of ongoing patient care.  

“We know that staff and patients have formed a strong attachment to Moorfields at City Road over the years and will work with them to make sure that we do justice to honouring its legacy when we move to St Pancras.  We will also maintain our strong links with Islington Council as plans for City Road Island progress.”

Read more

Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Retail

Related Topics

  • London business

Trending Articles

  • Revealed: KPMG and Deloitte offer bumper redundancy packages to slash headcount

  • Motsepe backed to succeed Fifa’s Infantino by South African minister

  • Brewdog owner shrugs off James Watt takeover bid

  • Finsbury lines up Games Workshop splurge using merger windfall

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

More from City PM

  • Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Mead Johnson Welcomes Defense Verdict in Collins Case

    Business Wire
  • FCA charges City lawyer with insider dealing over maternity brand acquisition

    Legal
    The FCA said in June any scheme must keep the market afloat in order to curb rising costs for consumers.
  • Balbec Capital Acquires Funding 365, A UK Specialist Property Lender

    Business Wire
  • Azalea Vision Awarded Prestigious EIC Accelerator Funding to Advance Smart Contact Lens into Clinical Development

    Business Wire
  • Why investors will be keeping a close eye on rugby’s Nations Championship

    Sport Business
    GettyImages 2247278074 features a professional meeting with diverse business executives discussing corporate strategy in a...
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook